High Point Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
High Point Wealth Management's LLY Position: Q3 2026 in Review
High Point Wealth Management increased its Eli Lilly (LLY) stake by 11% in Q3 2026, buying an estimated $9.44K and bringing the position to 78 shares worth $90.3K. The position accounts for 0.07% of the portfolio, ranked #117.
High Point Wealth Management first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- High Point Wealth Management held 78 shares of Eli Lilly worth $90.3K as of Q3 2026.
- High Point Wealth Management bought 8 Eli Lilly shares in Q3 2026, an estimated $9.44K.
- Eli Lilly made up 0.07% of High Point Wealth Management's portfolio in Q3 2026, its #117 holding.
- High Point Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on High Point Wealth Management's 13F filing for Q3 2026, filed 5 Nov 2026.